Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $1.55 billion. The enterprise value is $1.06 billion.

Market Cap	1.55B
Enterprise Value	1.06B

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ORKA has 48.41 million shares outstanding.

Current Share Class	48.41M
Shares Outstanding	48.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+4.68%
Owned by Insiders (%)	2.39%
Owned by Institutions (%)	70.10%
Float	31.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.21
P/TBV Ratio	3.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.94, with a Debt / Equity ratio of 0.00.

Current Ratio	16.94
Quick Ratio	16.65
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-937.23

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-25.62%
Revenue Per Employee	n/a
Profits Per Employee	-$2.98M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+52.81%
50-Day Moving Average	28.74
200-Day Moving Average	17.10
Relative Strength Index (RSI)	61.61
Average Volume (20 Days)	643,783

Short Selling Information

The latest short interest is 5.83 million, so 12.04% of the outstanding shares have been sold short.

Short Interest	5.83M
Short Previous Month	5.50M
Short % of Shares Out	12.04%
Short % of Float	18.47%
Short Ratio (days to cover)	13.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-125.08M
Pretax Income	-109.24M
Net Income	-83.57M
EBITDA	-125.00M
EBIT	-125.08M
Earnings Per Share (EPS)	-$1.95

Balance Sheet

The company has $349.16 million in cash and $1.91 million in debt, giving a net cash position of $499.01 million or $10.31 per share.

Cash & Cash Equivalents	349.16M
Total Debt	1.91M
Net Cash	499.01M
Net Cash Per Share	$10.31
Equity (Book Value)	486.79M
Book Value Per Share	10.00
Working Capital	334.20M

Cash Flow

In the last 12 months, operating cash flow was -$89.69 million and capital expenditures -$181,182, giving a free cash flow of -$89.87 million.

Operating Cash Flow	-89.69M
Capital Expenditures	-181,182
Free Cash Flow	-89.87M
FCF Per Share	-$1.86

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-5.37%
FCF Yield	-5.78%

Analyst Forecast

The average price target for ORKA is $48.20, which is 50.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$48.20
Price Target Difference	50.20%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 1:12.

Last Split Date	Sep 3, 2024
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a